Clinical Trials Directory

Trials / Completed

CompletedNCT04190888

Sickle Cell Uric Acid (SCUA) - Cohort Repository

Status
Completed
Phase
Study type
Observational
Enrollment
78 (actual)
Sponsor
Virginia Commonwealth University · Academic / Other
Sex
All
Age
5 Years – 29 Years
Healthy volunteers
Not accepted

Summary

The purpose of this research is to study the causes of Sickle Cell kidney disease, as well as to collect and store samples and information about people with Sickle Cell Disease.

Detailed description

Sickle Cell Disease causes kidney injury over time, but it is not clear why some individuals have very significant chronic kidney disease and why some do not. The purpose of this research is to study whether having high levels of 'uric acid,' which is a naturally occurring molecule in the body that may increase kidney injury and systemic inflammation, accelerates the progression of chronic kidney disease over time. Researchers will measure the number of participants that have high uric acid levels at the beginning of the study, as well as the number of participants that develop new high levels throughout the study. The study will also try to determine what causes the high uric acid levels in some patients but not others. The results of this study could help understand kidney injury and uric acid in sickle cell disease better.

Conditions

Interventions

TypeNameDescription
OTHERNo interventionNo intervention - observational study

Timeline

Start date
2019-07-01
Primary completion
2021-12-31
Completion
2021-12-31
First posted
2019-12-09
Last updated
2022-02-04

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04190888. Inclusion in this directory is not an endorsement.